Jejum intermitente no emagrecimento: uma revisão sistemática

Among the various nutritional strategies that exist to facilitate weight loss, one of the most popular is the Intermittent Fasting (JI) diet. Typically, JI is defined as a total or partial restriction in energy intake between one to three days per week, or a complete restriction on energy intake for a defined period of the day. This study is a review article that aimed at the broad view of the intermittent fasting diets and evidenced the effects of the evaluation process of the nutritional strategy. A search was carried out in the Pubmed, Lilacs, Medline and the Scielo e-libraries to identify scientific papers published between 2007 and 2017. A total of 44 articles were selected, containing the descriptors in Portuguese and English: "fasting", "Calorie restriction" and "weight loss". Overall, many of the studies reviewed suggest that JI is effective for weight reduction, including benefits such as improved glucose metabolism, cardiovascular health, and maintenance of lean mass. However, it can be verified that of the studies developed in humans, published in the timeframe of the research, involved mainly short-term JI and groups with small numbers of individuals, thus questioning possible biological adaptations and future effects on The risk of diseases that may occur in individuals who practice this diet.Dentre as várias estratégias nutricionais que existem para faciltiar a perda de peso, uma das mais populares é a dieta do Jejum Intermitente (JI). Normalmente, JI é definido por uma restrição total ou parcial na ingestão de energia entre um a três dias por semana, ou uma restrição completa na ingestão de energia por um período definido do dia. Este estudo trata-se de um artigo de revisão que objetivou fornecer visão ampla das dietas de jejum intermitentes e evidenciar os possíveis efeitos no processo de emagrecimento por meio dessa estratégia nutricional. Foi realizada uma busca nas bases de dados Pubmed, Lilacs, Medline e a biblioteca eletrônica Scielo a fim de identificar artigos científicos publicados no período de 2007 a 2017. Foram selecionados 44 artigos, contendo os descritores, em português e inglês: “jejumâ€, “restrição calórica†e “emagrecimento’’. De forma geral, muitos dos estudos analisados sugerem que o JI é eficiente para redução de peso, incluindo benefícios como, melhora do metabolismo da glicose, saúde cardiovascular e manutenção de massa magra. No entanto, pode ser verificado que dos estudos desenvolvidos em humanos, publicados no intervalo de tempo foco da pesquisa, envolveram principalmente JI de curto prazo e grupos com número reduzido de indivíduos, ficando, desta forma, questionamento sobre possíveis adaptações biológicas e efeitos futuros sobre o risco de doenças que possam ocorrer em indivíduos que praticam essa dieta

Jejum intermitente no emagrecimento: uma revisão sistemática

Among the various nutritional strategies that exist to facilitate weight loss, one of the most popular is the Intermittent Fasting (JI) diet. Typically, JI is defined as a total or partial restriction in energy intake between one to three days per week, or a complete restriction on energy intake for a defined period of the day. This study is a review article that aimed at the broad view of the intermittent fasting diets and evidenced the effects of the evaluation process of the nutritional strategy. A search was carried out in the Pubmed, Lilacs, Medline and the Scielo e-libraries to identify scientific papers published between 2007 and 2017. A total of 44 articles were selected, containing the descriptors in Portuguese and English: "fasting", "Calorie restriction" and "weight loss". Overall, many of the studies reviewed suggest that JI is effective for weight reduction, including benefits such as improved glucose metabolism, cardiovascular health, and maintenance of lean mass. However, it can be verified that of the studies developed in humans, published in the timeframe of the research, involved mainly short-term JI and groups with small numbers of individuals, thus questioning possible biological adaptations and future effects on The risk of diseases that may occur in individuals who practice this diet.Dentre as várias estratégias nutricionais que existem para faciltiar a perda de peso, uma das mais populares é a dieta do Jejum Intermitente (JI). Normalmente, JI é definido por uma restrição total ou parcial na ingestão de energia entre um a três dias por semana, ou uma restrição completa na ingestão de energia por um período definido do dia. Este estudo trata-se de um artigo de revisão que objetivou fornecer visão ampla das dietas de jejum intermitentes e evidenciar os possíveis efeitos no processo de emagrecimento por meio dessa estratégia nutricional. Foi realizada uma busca nas bases de dados Pubmed, Lilacs, Medline e a biblioteca eletrônica Scielo a fim de identificar artigos científicos publicados no período de 2007 a 2017. Foram selecionados 44 artigos, contendo os descritores, em português e inglês: “jejum”, “restrição calórica” e “emagrecimento’’. De forma geral, muitos dos estudos analisados sugerem que o JI é eficiente para redução de peso, incluindo benefícios como, melhora do metabolismo da glicose, saúde cardiovascular e manutenção de massa magra. No entanto, pode ser verificado que dos estudos desenvolvidos em humanos, publicados no intervalo de tempo foco da pesquisa, envolveram principalmente JI de curto prazo e grupos com número reduzido de indivíduos, ficando, desta forma, questionamento sobre possíveis adaptações biológicas e efeitos futuros sobre o risco de doenças que possam ocorrer em indivíduos que praticam essa dieta

Antidiabetic effects of galactomannans from Adenanthera pavonina L. in streptozotocin-induced diabetic mice

Objective: To evaluate the antidiabetic effect of galactomannans extracted from Adenanthera pavonina's L. seeds (GAP) in streptozotocin (STZ) induced diabetic mice. Methods: The preliminary galactomannan yield from Adenanthera pavonina L. plant and extraction products composition were evaluated. Various chemical characterization methods like thin layer chromatography, Fourier transform infrared spectroscopy, 1H and 13C nuclear magnetic resonance, and molecular weight by gel permeation chromatography have been employed to characterize the extracted galactomannan. The mice were divided in four groups: Normal control, diabetic control, GAP (1% and 2%) treated and standard drug treated groups. Diabetic mice received treatment daily for 30 d. Diabetes was induced by STZ at a single dose of 120 mg/kg. Body weight, water and food intake, fasting blood glucose, total cholesterol and triglycerides were measured. Histopathological analysis of pancreas and liver were performed to evaluate STZ-induced tissue injuries. Results: The isolated and extracted galactomannan from Adenanthera pavonina was confirmed by various chemical characterization methods. GAP exhibited a 1.46:1 mannose: galactose ratio, and high molar weight. Both GAP enriched food decreased glycaemia, total cholesterol and triacylglycerol. GAP didn't interfere on food intakes or body weight, although it increased water intake. Furthermore, the relative liver weight indicated toxic galactomannan effects on the histopathological changes of the pancreas in STZ induced diabetes. Conclusions: It is concluded that GAP is a natural product that contains potent galactomannan and is useful in preventing and treating diabetes

Antihypercholesterolemic Effects of Fruit Aqueous Extract of Copernicia prunifera (Miller) H. E. Moore in Mice Diet-Induced Hypercholesterolemia

The present objective of the investigation is to evaluate the antihypercholesterolemic activity of the aqueous fruit pulp extract (APE) of Copernicia prunifera (Miller) H. E. Moore (Arecaceae family). Various chemical characterization methods like thin layer chromatography, Fourier transform infrared spectroscopy, 1H and 13C NMR, and molecular weight by gel permeation chromatography have been employed to characterize the extracted pectin. The present study demonstrated that hypercholesterolemic diet (HD) created hypercholesterolemia, caused significant increases in body weight, total cholesterol, and low-density lipoprotein, and caused decreases in high-density lipoprotein in serum compared with SD group. Two doses (APE 150 and 300 mg/Kg b.w./day) were administered to hyperlipidemic mice for 90 days. APE reversed body weight changes, changed serum lipids to normal values, and significantly inhibited the changes of lipid peroxidation and inflammation in the liver tissues. The renal parameters analyzed (urea and creatinine) altered by diet were reverted to normal values. Our results revealed that aqueous fruit pulp extracts of carnauba reduced hypercholesterolemia showing a potential preventive effect against cardiovascular diseases without side effects cause

Antihyperglycemic effect of Passiflora glandulosa cav. fruit rinds flour in streptozotocin-induced diabetic mice

Objective: To investigate the effect of administration of Passiflora glandulosa (P. glandulosa) fruit rinds flour on streptozotocin (STZ)-induced diabetic mice. Methods: The preliminary phytochemical screening and parameters such as centesimal composition and brine shrimp toxicity were evaluated. For in vivo study Swiss female mice were divided into four groups: NC-normal control; DC-diabetic control animals receiving saline; MET-diabetic animals receiving metformin (200 mg/kg); PFRF-diabetic animals receiving P. glandulosa fruit rinds flour (200 mg/kg). All of them were treated for 28 d. STZ was used in a single dose of 120 mg/kg to establish diabetic models. Body weight, water and food intake, fasting blood glucose were measured. Histopathological analysis of pancreas and liver were performed to evaluate STZ-induced tissue injuries. Results: Phytochemical screening showed the presence of flavanones and triterpenoids. The P. glandulosa fruit rinds flour was non-toxic by the brine shrimp test. The fruit rinds flour also reduced the loss of body weight and significantly decreased food intake in the diabetic mice. Additionally, a significant reduction in blood glucose was observed for 15 d and this was maintained on 21 d and 28 d when compared with diabetic mice. Furthermore, the P. glandulosa fruit rinds flour has a favourable effect on the histopathological changes of the pancreas in STZ induced diabetes. Conclusions: It is concluded that P. glandulosa fruit rinds flour is a natural product that contains potent antioxidant compounds and presents good prospects for the improvement of diabetic mellitus by reducing serum glucose levels

p-Methoxycinnamic Acid Diesters Lower Dyslipidemia, Liver Oxidative Stress and Toxicity in High-Fat Diet Fed Mice and Human Peripheral Blood Lymphocytes

The pursuit of cholesterol lowering natural products with less side effects is needed for controlling dyslipidemia and reducing the increasing toll of cardiovascular diseases that are associated with morbidity and mortality worldwide. The present study aimed at the examining effects of p-methoxycinnamic acid diesters (PCO-C) from carnauba (Copernicia prunifera)-derived wax on cytotoxic, genotoxic responses in vitro and on dyslipidemia and liver oxidative stress in vivo, utilizing high-fat diet (HFD) chronically fed Swiss mice. In addition, we evaluated the effect of PCO-C on the expression of key cholesterol metabolism-related genes, as well as the structural interactions between PCO-C and lecithin-cholesterol acyl transferase (LCAT) in silico. Oral treatment with PCO-C was able to reduce total serum cholesterol and low-density lipoprotein (LDL) levels following HFD. In addition, PCO-C reduced excessive weight gain and lipid peroxidation, and increased the gene expression of LCAT following HFD. Furthermore, the high affinity of the studied compound (ΔG: −8.78 Kcal/mol) towards the active sites of mutant LCAT owing to hydrophobic and van der Waals interactions was confirmed using bioinformatics. PCO-C showed no evidence of renal and hepatic toxicity, unlike simvastatin, that elevated aspartate aminotransferase (AST) levels, a marker of liver dysfunction. Finally, PCO-C showed no cytotoxicity or genotoxicity towards human peripheral blood lymphocytes in vitro. Our results suggest that PCO-C exerts hypocholesterolemic effects. The safety of PCO-C in the toxicological tests performed and the reports of its beneficial biological effects render this a promising compound for the development of new cholesterol-lowering therapeutics to control dyslipidemia. More work is needed for further elucidating PCO-C role on lipid metabolism to support future clinical studies